Ce que nous faisons » Vue d’ensemble des licences » Licences du MPP » LOPINAVIR, RITONAVIR (LPV/r)

LOPINAVIR, RITONAVIR (LPV/r)

En décembre 2015, le MPP et AbbVie ont signé un nouvel accord de licence visant à accroître l’accès au lopinavir, ritonavir (LPV/r), un traitement de deuxième intention recommandé par l’OMS, dans l’ensemble des 54 pays africains.

Caractéristiques clés
Eligibility for sublicences Sublicences can be issued to any qualified entity worldwide.
Manufacturing Allows manufacturing of the active pharmaceutical ingredient and the finished formulation of LPV/r and RTV anywhere in the world.
Geographical scope for sale Allows for sale of LPV/r and RTV in all African countries.
Sales outside the licensed territory Sales outside Africa are permitted if no granted patent is being infringed. This includes cases in which a compulsory licence is issued.
Royalties The licence is royalty free.
Quality assurance Licensees must obtain approval from WHO Pre-qualification, or a Stringent Regulatory Authority. Where such approval is not yet available, temporary approval from a WHO Expert Review Panel may be obtained.
Combinations Sublicensees have the right to combine LPV/r or RTV with other ARVs and to develop suitable new fixed-dose combinations.
Data exclusivity Data exclusivity is waived in countries with such form of protection, thus facilitating regulatory approval of generics.
Patent disclosure The licence discloses the list of pending and granted patents on LPV/r and RTV worldwide.
Additional flexibilities for licensees Licensees have the right to challenge the validity of any of the licensed patents.
Liste des pays
Afrique du Sud, Algérie, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroun, Cap Vert, Chad, Comores, Côte d’Ivoire, Djibouti, Egypte, Erythrée, Ethiopie, Gabon, Gambie, Ghana, Guinée, Guinée Equatoriale, Guinée-Bissau, Ile Maurice, Kenya, Lesotho, Liberia, Libye, Madagascar, Malawi, Mali, Maroc, Mauritanie, Mauritius, Mozambique, Namibie, Niger, Nigeria, Ouganda, République Centrafricaine, République Démocratique du Congo, République du Congo, Rwanda, Sao Tomé-et-Principe, Senegal, Seychelles, Sierra Leone, Somalie, Soudan, Sud Soudan, Swaziland, Tanzania, Tanzanie, Tchad, Togo, Tunisia, Tunisie, Uganda, Zambia, Zambie, Zimbabwe

Génériqueurs partenaires et développeurs de produits

Cliquez sur le logo pour avoir accès à l’accord de sous-licence

Ce site web utilise des cookies pour vous assurer une expérience utilisateur optimale. En savoir plus